March 2020

Tutto Andra Bene

 

The media’s relentless fearmongering isn’t going to save anyone.
A world at risk (GPMB)
Information Disorder
 #chloroquine, real or fake news?

Much Ado about Practically Nothing? (covid.hi.is)
How to Lie with Statistics
The Essential Exponential!
The Lancet: Estimates of global seasonal influenza…
12 Experts Questioning the Coronavirus Panic

Is there a risk that mandatory forces will seize power in a real or perceived emergency?
The Shock Doctrine 2020
Narcissists, Reptiles and Memory holes

So I figured that the problem is the solution.
A guerrilla gardener in South Central LA

Flupocalypse

“Why were we so unprepared for a threat we knew about? After 2003, there was a burst of research, but it was short-lived. “From 2005, it became really difficult to get funding for work on SARS coronavirus,” says Rolf Hilgenfeld at the University of Lübeck, Germany. This was partly because, when SARS disappeared, there was no obvious market waiting for drugs or vaccines to treat it, says David Heymann at the London School of Hygiene and Tropical Medicine. Only big drug companies have the money and expertise to get drugs or vaccines through human trials, and without a market they can’t invest. But Hilgenfeld says agencies that fund research also lost interest, because “prominent virologists believed that SARS coronavirus was a one-time only thing”.”

~ New Scientist 7 March 2020

Why has Palli Thordarson gone viral?

Undue influence

US Debt Ceiling 2012 visualized
“No wonder, then, that the World Health Organisation (WHO) has talked of the “inherent conflict” between the legitimate business goals of the drug companies and the medical and social needs of the wider public.”

A growing number of us would like to try alternative (original) treatments for a number of ailments, but are thwarted in doing so by conflicting messages from authorities claiming to have our best interest at heart?

extraordinary profits made by drug companies.

Global pharma market will reach $1.12 trillion in 2022

Global Pharmaceutical Industry – Statistics & Facts

Regulatory capture

Scroll to Top